10.07.21 The Washington Post: GreenLight plans to launch a clinical trial in Africa next year Share: Share on Linkedin Share on Twitter Share on Facebook The Washington Post reports on GreenLight Biosciences’ plans to launch a clinical trial in Africa next year. The Washington Post reports on vaccines in Africa and mentions GreenLight Bioscience’s plans to launch a clinical trial in Africa next year. An extract is below: GreenLight Biosciences, a start-up company that has been making RNA for agricultural applications, is working toward making mRNA vaccines with a different manufacturing process that could be easier to scale up. GreenLight plans to launch a clinical trial in Africa next year. Read the full article here. Find out more about how GreenLight manufactures RNA here.